Trials / Completed
CompletedNCT02871362
Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the benefit and tolerability of IQP-AS-118 on the systolic and diastolic blood pressure (BP) and to explore the effects on parameters of lipid metabolism in subjects with elevated BP and low density lipoprotein cholesterol (LDL-C) levels in a pilot study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | IQP-AS-118 | Take one a day |
| DIETARY_SUPPLEMENT | Placebo | Take one a day |
Timeline
- Start date
- 2017-03-17
- Primary completion
- 2018-01-30
- Completion
- 2018-01-30
- First posted
- 2016-08-18
- Last updated
- 2019-03-04
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02871362. Inclusion in this directory is not an endorsement.